MedTrace Logo

Treatment and Medical Care of Patients With Moderate-to-severe Atopic Dermatitis - TREATswitzerland

NCT05819463 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 700

Last updated 2025-04-30

No results posted yet for this study

Summary

As structured and detailed data on the management of AD, a common chronic inflammatory skin disease which has a high impact on patients' quality of life and socioeconomic burden, are not available in Switzerland, the planned registry will overcome this gap. It will provide data on the medical care of patients with AD for health care research and allow to study the efficacy and safety of approved and available therapies for AD in daily life.

Conditions

Sponsors & Collaborators

  • Swiss Society of Dermatology and Venereology

    lead OTHER

Principal Investigators

  • Dagmar Simon, Prof. Dr. med. · Department of Dermatology, Inselspital

Eligibility

Min Age
12 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-06-02
Primary Completion
2032-05-31
Completion
2032-12-31

Countries

  • Switzerland

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05819463 on ClinicalTrials.gov